Logo image of NSRX

NASUS PHARMA LTD (NSRX) Stock Earnings & Estimates

USA - NYSE Arca - NYSEARCA:NSRX - IL0012181553 - Common Stock

6.5 USD
-0.55 (-7.8%)
Last: 1/20/2026, 10:16:43 AM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
NSRX revenue by date.NSRX revenue by date.
N/AN/AN/A
EBITDA
YoY % growth
NSRX ebitda by date.NSRX ebitda by date.
N/AN/AN/AN/AN/AN/A
EBIT
YoY % growth
NSRX ebit by date.NSRX ebit by date.
-4.1K-2.3K
43.90%		-2.2K
4.35%		N/A
-248,061.36%		N/A
-130.00%		N/A
-18.93%
Operating Margin
NSRX operating margin by date.NSRX operating margin by date.
N/AN/AN/AN/AN/AN/A
EPS
YoY % growth
NSRX eps by date.NSRX eps by date.
N/AN/AN/AN/AN/A
-44.53%		N/A
-19.19%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.04-0.05-0.14-0.39
Revenue
Q2Q % growth		N/AN/AN/A
EBITDA
Q2Q % growth		N/AN/AN/AN/A
EBIT
Q2Q % growth		N/AN/A-1.809M-4.8M
-436,274.55%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
NSRX Yearly EPS VS EstimatesNSRX Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 -0.2 -0.4 -0.6 -0.8 -1
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 27.89% N/A
RevenueN/A N/A N/A N/A